Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabina Chiaretti

Showing results (51-60 of 171) with videos related to

Pageof 18
Sort By:
Haematologica|January 9, 2025
Tyrosine kinase inhibitor discontinuation in nonallografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life studyMatteo Dragani, Michela Ansuinelli, Cristina Papayannidis, et al.
Vaccine: X|December 12, 2022
Humoral and T-cell mediated response after administration of mRNA vaccine BNT162b2 in frail populationsRoberta Campagna, Laura Mazzuti, Giuliana Guerrizio, et al.
Blood|October 18, 2003
Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigensRoberto Bellucci, Catherine J Wu, Sabina Chiaretti, et al.
Haematologica|February 14, 2013
TP53 mutations are frequent in adult acute lymphoblastic leukemia cases negative for recurrent fusion genes and correlate with poor response to induction therapySabina Chiaretti, Fulvia Brugnoletti, Simona Tavolaro, et al.
Leukemia & Lymphoma|September 7, 2018
IL7R overexpression in adult acute lymphoblastic leukemia is associated to JAK/STAT pathway mutations and identifies patients who could benefit from targeted therapiesValentina Gianfelici, Monica Messina, Francesca Paoloni, et al.
Leukemia|February 27, 2018
High PIM1 expression is a biomarker of T-cell acute lymphoblastic leukemia with JAK/STAT activation or t(6;7)(p21;q34)/TRB@-PIM1 rearrangementRoberta La Starza, Monica Messina, Valentina Gianfelici, et al.
British Journal of Haematology|June 1, 2011
AICDA expression in BCR/ABL1-positive acute lymphoblastic leukaemia is associated with a peculiar gene expression profileMonica Messina, Sabina Chiaretti, Ilaria Iacobucci, et al.
Hematological Oncology|August 17, 2021
Applicability of droplet digital polymerase chain reaction for minimal residual disease monitoring in Philadelphia-positive acute lymphoblastic leukaemiaMichela Ansuinelli, Irene Della Starza, Alessia Lauretti, et al.
Leukemia & Lymphoma|June 27, 2018
Autologous stem cell transplant in acute lymphoblastic leukemia: prognostic impact of pre-transplant minimal residual diseaseSaveria Capria, Sara Pepe, Silvia Maria Trisolini, et al.
Haematologica|December 31, 2011
NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLLIlaria Del Giudice, Davide Rossi, Sabina Chiaretti, et al.
Pageof 18

Showing results (51-60 of 171) with videos related to

Sort By:
Pageof 18
Haematologica|January 9, 2025
Tyrosine kinase inhibitor discontinuation in nonallografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life studyMatteo Dragani, Michela Ansuinelli, Cristina Papayannidis, et al.
Vaccine: X|December 12, 2022
Humoral and T-cell mediated response after administration of mRNA vaccine BNT162b2 in frail populationsRoberta Campagna, Laura Mazzuti, Giuliana Guerrizio, et al.
Blood|October 18, 2003
Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigensRoberto Bellucci, Catherine J Wu, Sabina Chiaretti, et al.
Haematologica|February 14, 2013
TP53 mutations are frequent in adult acute lymphoblastic leukemia cases negative for recurrent fusion genes and correlate with poor response to induction therapySabina Chiaretti, Fulvia Brugnoletti, Simona Tavolaro, et al.
Leukemia & Lymphoma|September 7, 2018
IL7R overexpression in adult acute lymphoblastic leukemia is associated to JAK/STAT pathway mutations and identifies patients who could benefit from targeted therapiesValentina Gianfelici, Monica Messina, Francesca Paoloni, et al.
Leukemia|February 27, 2018
High PIM1 expression is a biomarker of T-cell acute lymphoblastic leukemia with JAK/STAT activation or t(6;7)(p21;q34)/TRB@-PIM1 rearrangementRoberta La Starza, Monica Messina, Valentina Gianfelici, et al.
British Journal of Haematology|June 1, 2011
AICDA expression in BCR/ABL1-positive acute lymphoblastic leukaemia is associated with a peculiar gene expression profileMonica Messina, Sabina Chiaretti, Ilaria Iacobucci, et al.
Hematological Oncology|August 17, 2021
Applicability of droplet digital polymerase chain reaction for minimal residual disease monitoring in Philadelphia-positive acute lymphoblastic leukaemiaMichela Ansuinelli, Irene Della Starza, Alessia Lauretti, et al.
Leukemia & Lymphoma|June 27, 2018
Autologous stem cell transplant in acute lymphoblastic leukemia: prognostic impact of pre-transplant minimal residual diseaseSaveria Capria, Sara Pepe, Silvia Maria Trisolini, et al.
Haematologica|December 31, 2011
NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLLIlaria Del Giudice, Davide Rossi, Sabina Chiaretti, et al.
Pageof 18